Abstract
The ability of the dotLab™ System to concurrently perform monitoring of protein-protein interactions in real-time, while using different assay formats, overcomes the traditional limitations of multiplexed end-point assays.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Borisenko, V. et al. Diffractive optics technology: a novel detection technology for immunoassays. Clin. Chem. 52, 2168–2170 (2006).
Acknowledgements
We recognize D. Wong of Axela Biosensors, Inc. for his assistance in developing this application note.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Disclaimer
This article was submitted to Nature Methods by a commercial organization and has not been peer reviewed. Nature Methods takes no responsibility for the accuracy or otherwise of the information provided.
Rights and permissions
About this article
Cite this article
Houle, JF., Kumaraswamy, S. Solving the multiplexing–dynamic range conundrum with Diffractive Optics Technology (dot™). Nat Methods 4, i–ii (2007). https://doi.org/10.1038/nmeth1000
Issue date:
DOI: https://doi.org/10.1038/nmeth1000
